Form 4: Encompass Health Director Acquires Additional Shares Through Dividend Reinvestment
SEC Form 4 Filing
Terrance Williams, a director at Encompass Health Corp, acquired 23 shares of common stock through a dividend reinvestment program on April 15, 2025.
Summary
- On April 15, 2025, Terrance Williams, a director of Encompass Health Corp, acquired 23 shares of Encompass Health common stock.
- The acquisition was a result of a dividend reinvestment related to outstanding restricted stock units (RSUs).
- Encompass Health paid a dividend of $0.17 per share on its common stock on April 15, 2025.
- The closing price of Encompass Health's common stock on the dividend payment date was $102.30.
- Following the transaction, Williams directly owns 13,670 shares of Encompass Health common stock.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (dividend reinvestment) by a company director, suggesting a neutral sentiment. It indicates confidence but isn't a major event.
Positives
- The director's participation in the dividend reinvestment program demonstrates confidence in the company's future.
Industry Context
Dividend reinvestment programs are a common way for company insiders to increase their ownership stake, aligning their interests with those of shareholders.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals director confidence.
Key Dates
| Date | Description |
|---|---|
| 04/15/2025 | Date of transaction: Director acquired shares through dividend reinvestment. |
| 04/16/2025 | Date of signature on the Form 4 filing. |
Keywords
Encompass Health, Director, Terrance Williams, Dividend Reinvestment, RSUs, Common Stock, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.